Up next

Autoplay

EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer

3 Views • 07/14/23
Share
Embed
administrator
administrator
Subscribers
0

Lyudmila Bazhenova, MD, reviews EGFR exon 20 insertions and treatments being studied in this setting, including amivantamab, osimertinib, and poziotinib.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay